A Hamilton-Jacobi-Bellman approach to optimal trade executionFORSYTH, Peter A.Applied numerical mathematics. 2011, Vol 61, Num 2, pp 241-265, issn 0168-9274, 25 p.Article

A numerical scheme for the impulse control formulation for pricing variable annuities with a guaranteed minimum withdrawal benefit (GMWB)ZHULIANG CHEN; FORSYTH, Peter A.Numerische Mathematik. 2008, Vol 109, Num 4, pp 535-569, issn 0029-599X, 35 p.Article

A SEMI-LAGRANGIAN APPROACH FOR NATURAL GAS STORAGE VALUATION AND OPTIMAL OPERATIONZHULIANG CHEN; FORSYTH, Peter A.SIAM journal on scientific computing (Print). 2009, Vol 30, Num 1, pp 339-368, issn 1064-8275, 30 p.Article

On the selection of primary variables in numerical formulation for modeling multiphase flow in porous mediaWU, Yu-Shu; FORSYTH, Peter A.Journal of contaminant hydrology. 2001, Vol 48, Num 3-4, pp 277-304, issn 0169-7722Article

Numerical solution of two asset jump diffusion models for option valuationCLIFT, Simon S; FORSYTH, Peter A.Applied numerical mathematics. 2008, Vol 58, Num 6, pp 743-782, issn 0168-9274, 40 p.Article

Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or CyclophosphamideXUE OING LUN; JANG, Ji-Hyun; MCCART, J. Andrea et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2777-2788, issn 1078-0432, 12 p.Article

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiationLEVIN, Victor A; PHUPHANICH, Surasak; ALFRED YUNG, W. K et al.Journal of neuro-oncology. 2006, Vol 78, Num 3, pp 295-302, issn 0167-594X, 8 p.Article

Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid TumorsYUSHUI WU; XUEQING LUN; FORSYTH, Peter A et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 1218-1227, issn 1078-0432, 10 p.Article

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomasXUEQING LUN; WENQING YANG; FORSYTH, Peter A et al.Cancer research (Baltimore). 2005, Vol 65, Num 21, pp 9982-9990, issn 0008-5472, 9 p.Article

REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumorsMORRIS, Don G; XIAOLAN FENG; DIFRANCESCO, Lisa M et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 696-706, issn 0167-6997, 11 p.Article

A Phase 1/2 Study of Orally Administered Synthetic Hypericin for Treatment of Recurrent Malignant GliomasCOULDWELL, William T; SURNOCK, Amy A; TOBIA, Alfonso J et al.Cancer. 2011, Vol 117, Num 21, pp 4905-4915, issn 0008-543X, 11 p.Article

Imaging correlates of molecular signatures in oligodendrogliomasMEGYESI, Joseph F; KACHUR, Edward; CAIRNCROSS, J. Gregory et al.Clinical cancer research. 2004, Vol 10, Num 13, pp 4303-4306, issn 1078-0432, 4 p.Article

Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: Racine and nonhuman primatesWEN QING YANG; XUEQING LUN; NISHIKAWA, Sandra G et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8561-8576, issn 1078-0432, 16 p.Article

Prophylactic anticonvulsants in patients with brain tumourFORSYTH, Peter A; WEAVER, Susan; FULTON, Dorcas et al.Canadian journal of neurological sciences. 2003, Vol 30, Num 2, pp 106-112, issn 0317-1671, 7 p.Article

Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastomaWEN QING YANG; SENGER, Donna; WETMORE, Cynthia et al.Cancer research (Baltimore). 2003, Vol 63, Num 12, pp 3162-3172, issn 0008-5472, 11 p.Article

Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological TherapeuticTHIRUKKUMARAN, Chandini M; NODWELL, Michael J; NISHIKAWA, Sandra et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 6, pp 2435-2444, issn 0008-5472, 10 p.Article

Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with RapamycinXUEQING LUN; ALAIN, Tommy; ZEMP, Franz J et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 596-606, issn 0008-5472, 11 p.Article

Targeting human medulloblastoma : Oncolytic virotherapy with myxoma virus is enhanced by rapamycinXUE QING LUN; HONGYUAN ZHOU; FORSYTH, Peter A et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8818-8827, issn 0008-5472, 10 p.Article

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV^ΔM51) on multifocal and invasive gliomasXUEQING LUN; SENGER, Donna L; PARNEY, Ian et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 21, pp 1546-1557, issn 0027-8874, 12 p.Article

Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cellsNUTTALL, Robert K; PENNINGTON, Caroline J; TAPLIN, Jennifer et al.Molecular cancer research. 2003, Vol 1, Num 5, pp 333-345, issn 1541-7786, 13 p.Article

Altered subcellular localization and low frequency of mutations of ING1 in human brain tumorsVIEYRA, Diego; SENGER, Donna L; TOYALN, Tatsuya et al.Clinical cancer research. 2003, Vol 9, Num 16, pp 5952-5961, issn 1078-0432, 10 p., 1Article

Reovirus as an oncolytic agent against experimental human malignant gliomasWILCOX, M. Elizabeth; YANG, Wenqing; FORSYTH, Peter A et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 12, pp 903-912, issn 0027-8874Article

Long-term survivors of glioblastoma: Statistical aberration or important unrecognized molecular subtype?SENGER, Donna; CAIRNCROSS, J. Gregory; FORSYTH, Peter A. J et al.The Cancer journal (Sudbury, Mass. Print). 2003, Vol 9, Num 3, pp 214-221, issn 1528-9117, 8 p.Article